Latest filing published 03 Sept 2026 for Devyser Diagnostics AB, €11k. Read the official filing
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Mia Arnhult across 4 companies, led by Devyser Diagnostics AB, Logistea AB (publ) and Logistea AB. In total, 47 filings cover trades dated from 3 March 2025 to 3 September 2026.
Market trades split into 30 purchases (€3.6M) and 4 sales (€123.2M). The net balance comes to €119.6M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2026, the count stands at 19 purchases and 2 sales.
In size, the median ticket on the buying side is €29k. Scaled by market value, the purchases weigh a median 0.011% of market cap (sample: 30 purchases). Of 30 purchases, 21 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. After 5 purchases with a full 90-day history, the hit rate stands at 60% and the median 90-day move at +6.3%. These figures describe past trades and do not predict future prices.
The record was last updated on 3 September 2026 with an open-market purchase (€11k) in Devyser Diagnostics AB. Typically, a trade is published a median of 2 days after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 47 declarations